Cogent Biosciences (COGT) Return on Capital Employed (QoQ) (2018 - 2026)

Cogent Biosciences (COGT) Return on Capital Employed (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Cogent Biosciences 6.87 Bn 6.87 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1,197.00
Dec 31, 2025 5,280.00
Sep 30, 2025 2,891.00
Jun 30, 2025 -2,321.00
Mar 31, 2025 -2,055.00
Dec 31, 2024 -1,832.00
Sep 30, 2024 -1,436.00
Jun 30, 2024 425.00
Mar 31, 2024 677.00
Dec 31, 2023 -1,316.00
Sep 30, 2023 -51.00
Jun 30, 2023 462.00
Mar 31, 2023 -1,010.00
Dec 31, 2022 -1,121.00
Sep 30, 2022 367.00
Jun 30, 2022 315.00
Mar 31, 2022 -1,015.00
Dec 31, 2021 -666.00
Sep 30, 2021 1,511.00
Jun 30, 2021 -736.00